M&G plc’s RxSight RXST Stock Holding History

M&G plc’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-159,005	Closed	-$9.54M	–	431
2024 Q2	$9.54M	Buy	159,005 +17,577	+12%	+$1M	0.04%	205
2024 Q1	$7.35M	Buy	+141,428	New	+$6.94M	0.03%	261

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G plc's RXST Position: Q3 2024 in Review

M&G plc sold out of RxSight (RXST) in Q3 2024, closing a stake of 159,005 shares — an estimated $9.54M sold.

M&G plc first reported a position in RXST in Q1 2024 and held it in 2 quarters. The position peaked at $9.54M in Q2 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

M&G plc reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
M&G plc sold 159,005 RxSight shares in Q3 2024, an estimated $9.54M.
M&G plc first reported a position in RxSight in Q1 2024 and held it in 2 quarters.
M&G plc's RxSight position peaked at $9.54M in Q2 2024.
214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on M&G plc's 13F filing for Q3 2024, filed 31 Oct 2024.